Optimizing Outcomes in Venous Thromboembolism Among Hospitalized Medically Ill Patients Through an Integrated Risk Assessment Program
Advertisement
Advertisement
Trending on AJMC
1
FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads
2
Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH
3
Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again
4
Medicare’s 3-Day Rule Reinstatement Lengthened Hospital Stays Without Cost, Outcome Benefits
5
